Respiratory Tract Viruses Flashcards
1
Q
Examples of resp tract viruses (6)
A
- Influenza (orthomyxovirus)
- Parainfluenza (paramyxovirus)
- Respiratory Syncytial Virus, metapneumovirus (paramyxovirus)
- Adenovirus
- Rhinovirus (picornavirus)
- Coronavirus
2
Q
Structure of influenza virus
A
- Envelope
- Haemagglutinin - for attachment to host cells, antigenic variation
- Neuraminidase - facilitates release of virus from infected cell - Nucleocapsid
- 8 discrete RNA segments
- 3 types of RNA polymerase
3
Q
Variations of influenza virus
A
- Type specific antigenicity - soluble/s antigen in ribonucleoprotein core
- Subtype specific antigenicity - based on H & N expressed
4
Q
Epidemiology of influenza
A
- Influenza A - pandemics
- Influenza B - periodic epidemics
- Influenza C - less common, mild, no outbreaks
- Epidemics result from antigenic variation
1. Antigenic shift - genetic reassortment leading to antigenic change of both surface components
2. Antigenic drift - spontaneous mutation leading to minor changes in haemagglutinin
5
Q
Transmission of influenza
A
Respiratory droplets
6
Q
Incubation period of influenza
A
Short, 1-4 days
7
Q
Symptoms of influenza (2)
A
- Abrupt onset of fever, myalgia, malaise, headache
- Sore throat, dry cough, sneezing, rhinorrhea - viral multiplication in resp epithelium causes desquamation & ciliary damage
8
Q
Complications of influenza (4)
A
- Pneumonia - primary viral, secondary bacterial (damage of bronchial mucosa) caused by strep pneum, staph aureus, h influenzae
- Myocarditis - inflamm of heart muscle
- Myositis - inflamm of skeletal muscle
- Reye’s syndrome
- assoc w influenza B & aspirin intake in children, high mortality
- cerebral edema, fatty degeneration of liver
9
Q
Diagnosis of influenza (3)
A
- Virus isolation (chick embryo, monkey kidney cells - typing by HI)
- IF of antigen in resp epithelial cells
- Serology
10
Q
Treatment of influenza (5)
A
- Antivirals - Neuraminidase inhibitors (Oseltamivir/tamiflu, Zanamivir/Relenza), Amantadine (influenza A)
- Symptomatic treatment, recognise & treat complications, exclude differential diagnoses
- Minimise spread by resp route
- Vaccine (antigens from 2 influenza A & 1 influenza B strain) - inactivated, killed (IM) or live (nasal spray), problems of timely preparation, short lived immunity, incomplete protection, Guillain-Barre syndrome
- Prophylactic immunisation (for high risk groups, risk periods eg winter)
11
Q
Structure of parainfluenza virus
A
enveloped helical RNA virus with no genetic recombination
12
Q
Variations of parainfluenza virus
A
four serotypes
- Type 1: Croup in infants
- Type 2: Epidemics in winter
- Type 3: Bronchiolitis & bronchopneumonia in young infants, croup in older infants
- Type 4: minor resp infection
13
Q
Epidemiology of parainfluenza
A
- infects animals & man
- infection acquired by age 5
14
Q
Symptoms of parainfluenza (4)
A
- Febrile common cold - sore throat, cough, hoarseness
- URTI - croup - acute laryngotracheobronchitis, cough, hoarseness; if severe, dyspnea, stridor, cyanosis (may req tracheostomy)
- LRTI - bronchiolitis, bronchopneumonia
- DDx - diphtheria, H. influenzae epiglottitis
15
Q
Diagnosis of parainfluenza (3)
A
- Tissue culture (monkey kidney cells, CPE by type 2, guinea pig RBC haemagglutination)
- IF of infected resp epithelial cells (antigen detection)
- Serology - detect antibodies to
- s (soluble antigen) - nucleocapsid - early
- v (viral antigen) - H & N - late